Finance

Lists
Why is USNA up 4.01%?
Dive Deeper
USNA:NYSE
USANA Health Sciences Inc
$13.24
+4.01%
(+0.51) 1D
$13.15
-0.68% (-0.090)
After hours
Closed: Nov 13, 4:00:03 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for USNA...
Open
$12.89
High
$13.48
Low
$12.89
Mkt. cap
244.63M
Avg. vol.
195.49K
Volume
167.45K
52-wk high
$23.59
52-wk low
$12.52
EPS
-$1.20
Beta
0.66
Shares outstanding
18.48M
No. of employees
2K
Open
$12.89
High
$13.48
Low
$12.89
Mkt. cap
244.63M
Avg. vol.
195.49K
Volume
167.45K
52-wk high
$23.59
52-wk low
$12.52
EPS
-$1.20
Beta
0.66
Shares outstanding
18.48M
No. of employees
2K
News stories
From web sources and news partners
Profile
USANA Health Sciences, Inc., or USANA, is an American direct sales company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors. Wikipedia
About USANA Health Sciences Inc
CEOKevin Guest
Employees1.57K
Founded1992
HeadquartersSalt Lake City, Utah, United States
SectorConsumer Staples
IndustryPersonal care products
Websiteusana.com
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Lebiedzinski
Sidoti
Hold
Maintained
$39.00
+194.6%
10/24/2025
Last report
Nov 4, 2026
Fiscal period
Q3 2026
-$0.11 / $0.11
-200.00%miss
Revenue / Est. (USD)
205.88M / 217.42M
-5.30%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jan 2026
Apr 2026
Jul 2026
Oct 2026
Revenue
226.20M
250.22M
223.27M
205.88M
Cost of goods sold
49.41M
59.44M
48.34M
48.72M
Cost of revenue
49.41M
59.44M
48.34M
48.72M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
159.54M
176.91M
165.79M
158.62M
Operating expense
159.54M
176.91M
165.79M
158.62M
Total operating expenses
208.95M
236.34M
214.13M
207.33M
Operating income
17.25M
13.87M
9.14M
-1.45M
Other non operating income
-14.00K
1.39M
501.00K
37.00K
EBT including unusual items
4.18M
15.46M
-18.90M
-804.00K
EBT excluding unusual items
17.61M
15.46M
10.24M
-804.00K
Income tax expense
5.77M
8.51M
9.05M
6.09M
Effective tax rate
138.19%
55.00%
-47.89%
-756.97%
Other operating expenses
-
-
-
-
Net income
-1.78M
7.52M
-21.38M
-5.56M
Net profit margin
-0.78%
3.00%
-9.58%
-2.70%
Earnings per share
0.60
0.61
-0.07
-0.11
Interest and investment income
495.00K
437.00K
595.00K
645.00K
Interest expense
-123.00K
-240.00K
-
-38.00K
Net interest expenses
372.00K
197.00K
595.00K
607.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
25.81M
22.15M
16.82M
6.23M
Gain or loss from assets sale
-2.22M
13.00K
13.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps